SFEE’s Announcement on the Price Bulletin
Athens, October 22, 2012 – The price bulletin issued reveals a multitude of significant errors when compared with current law in force.
Pharmaceutical companies support the effort to further rationalize the pharmaceutical budget by issuing this Price Bulletin. At the same time, however, we expect the immediate correction of the errors, so that the re-pricing process can be completed in a regular way in the coming days and the normal flow of market supply can be restored.
It is absolutely essential to abide by the principles governing the pricing regime and to respect the relevant law in force.